Community
TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.
France
2021 (5 Years)
Last online: No recent activity
Be the first to rate and review this company.
Provided by TrustFinance
Be the first to rate and review this company.
Warning
This company is currently Unproved.
Please be cautious of the potential risks!
License
A Grade License
Issued by globally renowned regulators, these licenses ensure the highest trader protection through strict compliance, fund segregation, insurance, and regular audits. Dispute resolution and adherence to AML/CTF standards further enhance security.
B Grade License
Granted by respected regional regulators, these licenses offer robust safety measures such as fund segregation, financial reporting, and compensation schemes. Though slightly less strict than Tier 1, they provide dependable regional protection.
C Grade License
Issued by regulators in emerging markets, these licenses offer basic protections such as minimum capital requirements and AML policies. Oversight is less stringent, so traders should exercise caution and verify safety measures.
D Grade License
From jurisdictions with minimal oversight, these licenses often lack key protections like fund segregation and insurance. While attractive for operational flexibility, they pose higher risks to traders.
Get to know Cleerly
Company Information
Get to know Cleerly
Cleerly is a health technology company focused on combating cardiovascular disease through its innovative, AI-driven platform. Founded by Dr. James K. Min, the company's mission is to prevent heart attacks by shifting the paradigm of heart care from reactive to proactive. Cleerly's FDA-cleared solutions analyze coronary computed tomography angiography (CCTA) scans to quantify and characterize atherosclerotic plaque, providing physicians with a more precise understanding of a patient's heart disease risk. This approach aims to deliver personalized, life-saving treatment plans long before a cardiac event occurs.
Industry
Contact
-
-
-
-
Social
Company hasn't updated its information.
Reviews
Total 0
Filter
5 Star
4 Star
3 Star
2 Star
1 Star
Sort by
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis